A carregar...

α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy

α1 Antitrypsin deficiency (AATD) increases the risk of chronic obstructive pulmonary disease (COPD), liver disease and other conditions. Although it is not a rare disease, it is a condition rarely diagnosed because of unawareness by most healthcare providers who manage subjects at risk. Testing reco...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Michael A. Campos, Jorge Lascano
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publishing 2014-10-01
Colecção:Therapeutic Advances in Respiratory Disease
Acesso em linha:https://doi.org/10.1177/1753465814542243
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!